Ian Frazer
|
Professor Ian Frazer AC, FRCPE, FRCPA, FAA, FTSE |
|
|---|---|
 |
|
| Born |
6 January 1953 Glasgow, Scotland |
| Residence | Brisbane, Australia |
| Nationality | Australian |
| Fields | Immunology |
| Institutions | Translational Research Institute, University of Queensland |
| Alma mater |
University of Edinburgh (B.Sc.), (M.B.B.S.); Walter and Eliza Hall Institute of Medical Research; University of Melbourne (M.D.) |
| Known for | HPV vaccine creation |
| Notable awards |
Australian of the Year (2006), Prime Minister's Prize for Science (2008), Australian Living Treasure (2012), Companion of the Order of Australia (2012) |
Ian Hector Frazer AC (born 6 January 1953) is a Scottish-born Australian scientist and founding CEO and Director of Research of the Translational Research Institute (Australia). Frazer and his colleagues developed and patented the basic technology behind the HPV vaccine against cervical cancer at The University of Queensland, now marketed as Gardasil and Cervarix; which was the second cancer preventing vaccine, and the first vaccine designed to prevent a cancer. Researchers at the National Cancer Institute, Georgetown University, and University of Rochester also contributed to the further development of the cervical cancer vaccine in parallel.
Frazer was born in Glasgow, Scotland. His parents were medical scientists, and he was drawn to science from a young age.
Frazer attended Aberdeen private school Robert Gordon's College. He chose to pursue medicine over an earlier interest in physics due to physics having fewer research opportunities, and he received his Bachelor of Science and Bachelor of Medicine and Bachelor of Surgery, at the University of Edinburgh in 1974 and 1977 respectively. It was during this time that he met his wife Caroline, whom he married in 1976. His 1978–79 residency was in the Edinburgh Eastern General Hospital, the Edinburgh Royal Infirmary and the Roodlands General Hospital in Haddington.
...
Wikipedia